Companies / Metacrine, Inc.
Metacrine, Inc.
MTCRCIK 1634379
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Oct 25, 2021 | Goodman Corey S 10% owner | Sell Open-market sale | Common Stock | $806.0K | -541K -18.12% | 2,443,421 | medium |
| Mar 23, 2023 | Klassen Preston CEO | Grant Grant or award | Common Stock | $395.8K | -842K -37.83% | 1,384,116 | low |
| Oct 27, 2022 | Leonard Braden Michael 10% owner | Buy Open-market buy | Common Stock | $299.3K | +768K +15.62% | 5,679,673 | medium |
| Dec 22, 2021 | Chang Carmen 10% owner | Sell Open-market sale | Common Stock | $289.3K | -289K -9.55% | 2,734,189 | medium |
| Dec 22, 2021 | New Enterprise Associates 16, L.P. 10% owner | Sell Open-market sale | Common Stock | $289.3K | -289K -9.55% | 2,734,189 | medium |
| Dec 22, 2021 | Makhzoumi Mohamad 10% owner | Sell Open-market sale | Common Stock | $289.3K | -289K -9.55% | 2,734,189 | medium |
| Dec 22, 2021 | Behbahani Ali 10% owner | Sell Open-market sale | Common Stock | $289.3K | -289K -9.55% | 2,734,189 | medium |
| Dec 22, 2021 | Sonsini Peter W. 10% owner | Sell Open-market sale | Common Stock | $289.3K | -289K -9.55% | 2,734,189 | medium |